000 01380 a2200409 4500
005 20250512023015.0
264 0 _c19860318
008 198603s 0 0 eng d
022 _a0278-5846
024 7 _a10.1016/0278-5846(85)90032-6
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aPecknold, J C
245 0 0 _aBuspirone: anxiolytic?
_h[electronic resource]
260 _bProgress in neuro-psychopharmacology & biological psychiatry
_c1985
300 _a639-42 p.
_bdigital
500 _aPublication Type: Clinical Trial; Comparative Study; Controlled Clinical Trial; Journal Article
650 0 4 _aAdult
650 0 4 _aAnti-Anxiety Agents
_xadverse effects
650 0 4 _aAnxiety
_xdrug therapy
650 0 4 _aBuspirone
650 0 4 _aClinical Trials as Topic
650 0 4 _aDiazepam
_xadverse effects
650 0 4 _aDouble-Blind Method
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aPsychiatric Status Rating Scales
650 0 4 _aPyrimidines
_xadverse effects
650 0 4 _aSex Factors
700 1 _aFamilamiri, P
700 1 _aChang, H
700 1 _aWilson, R
700 1 _aAlarcia, J
700 1 _aMcClure, D J
773 0 _tProgress in neuro-psychopharmacology & biological psychiatry
_gvol. 9
_gno. 5-6
_gp. 639-42
856 4 0 _uhttps://doi.org/10.1016/0278-5846(85)90032-6
_zAvailable from publisher's website
999 _c2874341
_d2874341